Cancer research expands body's own immune system to kill tumors

February 02, 2021

WASHINGTON, February 2, 2021 -- Scientists are hoping advances in cancer research could lead to a day when a patient's own immune system could be used to fight and destroy a wide range of tumors.

Cancer immunotherapy has some remarkable successes, but its effectiveness has been limited to a relatively small handful of cancers. In APL Bioengineering, by AIP Publishing, a team from Stanford University and Genentech describes how advances in engineering models of tumors can greatly expand cancer immunotherapy's effectiveness to a wider range of cancers.

"One of the biggest breakthroughs we've had in cancer research in decades is that we can modify the cells in your own immune system to make them kill cancer cells," said author Joanna Lee.

Using existing immunotherapy advances, scientists have figured out a way to make the T-cells already inside "hot" or inflamed tumors start fighting them. But that breakthrough does not help with "cold" or noninflamed tumors, because the immune cells are not in the right place.

"Now, a big push in drug discovery in cancer is how do how to make those cold tumors hot?" Lee said. "How do we get immune cells into those tumors?"

To do that, scientists need to first recreate those changes in a laboratory. While much research can be done in a 2D environment, like a petri dish, modeling the way immune cells interact with cancer requires a more advanced 3D environment.

Building the tumor microenvironment, Lee said, will require expertise from both biologists, like herself, and engineers, like co-author Ovijit Chaudhuri.

"Trying to merge those two fields together is what has made the 3D culture field really challenging," she said. "The reason it's so hard is we are not just talking about having a plate you throw some cells in. It is more like building a house."

A faithful 3D model for cold tumors would make the research leading to new cancer drugs faster and more efficient. Lee said that is a big deal in a field where proposed new treatments take years to be approved and an overwhelming 96.6 % of them fail.

"If we could translate the success we've had with inflamed tumors to cold tumors, that would be a huge breakthrough," Lee said. "That's what we are going for in building these 3D culture models."
-end-
The article "Perspective: Modeling the tumor immune microenvironment for drug discovery using 3D culture" is authored by Joanna Y. Lee and Ovijit Chaudhuri. The article will appear in APL Bioengineering on Feb. 2, 2021 (DOI: 10.1063/5.0030693). After that date, it can be accessed at https://aip.scitation.org/doi/10.1063/5.0030693.

ABOUT THE JOURNAL

APL Bioengineering is an open access journal publishing significant discoveries specific to the understanding and advancement of physics and engineering of biological systems. See http://aip.scitation.org/journal/apb.

American Institute of Physics

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.